A PP4 Holoenzyme Balances Physiological and Oncogenic Nuclear Factor-Kappa B Signaling in T Lymphocytes

Immunity

Volumn 37, Issue 4, 2012, Pages 697-708

  Brechmann, Markus ^a   Mock, Thomas ^a   Nickles, Dorothee ^a   Kiessling, Michael ^a   Weit, Nicole ^b   Breuer, Rebecca ^a   Müller, Wolfgang ^a   Wabnitz, Guido ^c   Frey, Felice ^a   Nicolay, Jan P ^a,d   Booken, Nina ^d   Samstag, Yvonne ^c   Klemke, Claus Detlev ^d   Herling, Marco ^b   Boutros, Michael ^a   Krammer, Peter H ^a   Arnold, Rüdiger ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HOLOENZYME; I KAPPA B KINASE; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN PHOSPHATASE 4 REGULATORY SUBUNIT 1; PROTEIN PHOSPHATASE 4C; SMALL INTERFERING RNA; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ARTICLE; CELL EXPANSION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; GENE SILENCING; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

BIOCATALYSIS; CELL DIFFERENTIATION; CELLS, CULTURED; HOLOENZYMES; HUMANS; I-KAPPA B KINASE; LYMPHOCYTE ACTIVATION; NF-KAPPA B; PHOSPHOPROTEIN PHOSPHATASES; RNA INTERFERENCE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84867749151     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2012.07.014     Document Type: Article

References (41)

1. Acuto O., Di Bartolo V., Michel F. Tailoring T-cell receptor signals by proximal negative feedback mechanisms. Nat. Rev. Immunol. 2008, 8:699-712.
2. Arnold R., Liou J., Drexler H.C.A., Weiss A., Kiefer F. Caspase-mediated cleavage of hematopoietic progenitor kinase 1 (HPK1) converts an activator of NFkappaB into an inhibitor of NFkappaB. J. Biol. Chem. 2001, 276:14675-14684.
3. Bonizzi G., Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004, 25:280-288.
4. Brenner D., Golks A., Kiefer F., Krammer P.H., Arnold R. Activation or suppression of NFkappaB by HPK1 determines sensitivity to activation-induced cell death. EMBO J. 2005, 24:4279-4290.
5. Brewis N.D., Street A.J., Prescott A.R., Cohen P.T.W. PPX, a novel protein serine/threonine phosphatase localized to centrosomes. EMBO J. 1993, 12:987-996.
6. Chen G.I., Tisayakorn S., Jorgensen C., D'Ambrosio L.M., Goudreault M., Gingras A.C. PP4R4/KIAA1622 forms a novel stable cytosolic complex with phosphoprotein phosphatase 4. J. Biol. Chem. 2008, 283:29273-29284.
7. Chew J., Biswas S., Shreeram S., Humaidi M., Wong E.T., Dhillion M.K., Teo H., Hazra A., Fang C.C., López-Collazo E., et al. WIP1 phosphatase is a negative regulator of NF-kappaB signalling. Nat. Cell Biol. 2009, 11:659-666.
8. Chowdhury D., Xu X.Z., Zhong X.Y., Ahmed F., Zhong J.N., Liao J., Dykxhoorn D.M., Weinstock D.M., Pfeifer G.P., Lieberman J. A PP4-phosphatase complex dephosphorylates gamma-H2AX generated during DNA replication. Mol. Cell 2008, 31:33-46.
9. Compagno M., Lim W.K., Grunn A., Nandula S.V., Brahmachary M., Shen Q., Bertoni F., Ponzoni M., Scandurra M., Califano A., et al. Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. Nature 2009, 459:717-721.
10. Düwel M., Welteke V., Oeckinghaus A., Baens M., Kloo B., Ferch U., Darnay B.G., Ruland J., Marynen P., Krappmann D. A20 negatively regulates T cell receptor signaling to NF-kappaB by cleaving Malt1 ubiquitin chains. J. Immunol. 2009, 182:7718-7728.
11. Eitelhuber A.C., Warth S., Schimmack G., Düwel M., Hadian K., Demski K., Beisker W., Shinohara H., Kurosaki T., Heissmeyer V., Krappmann D. Dephosphorylation of Carma1 by PP2A negatively regulates T-cell activation. EMBO J. 2011, 30:594-605.
12. Ghosh S., Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002, 109:S81-S96.
13. Gingras A.C., Caballero M., Zarske M., Sanchez A., Hazbun T.R., Fields S., Sonenberg N., Hafen E., Raught B., Aebersold R. A novel, evolutionarily conserved protein phosphatase complex involved in cisplatin sensitivity. Mol. Cell. Proteomics 2005, 4:1725-1740.
14. Häcker H., Karin M. Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006, 2006:re13.
15. Hayden M.S., Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004, 18:2195-2224.
16. Hayden M.S., Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008, 132:344-362.
17. Herling M., Khoury J.D., Washington L.T., Duvic M., Keating M.J., Jones D. A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood 2004, 104:328-335.
18. Hwang S.T., Janik J.E., Jaffe E.S., Wilson W.H. Mycosis fungoides and Sézary syndrome. Lancet 2008, 371:945-957.
19. Hymowitz S.G., Wertz I.E. A20: from ubiquitin editing to tumour suppression. Nat. Rev. Cancer 2010, 10:332-341.
20. Kiessling M.K., Klemke C.D., Kaminski M.M., Galani I.E., Krammer P.H., Gülow K. Inhibition of constitutively activated nuclear factor-kappaB induces reactive oxygen species- and iron-dependent cell death in cutaneous T-cell lymphoma. Cancer Res. 2009, 69:2365-2374.
21. Kiessling M.K., Oberholzer P.A., Mondal C., Karpova M.B., Zipser M.C., Lin W.M., Girardi M., Macconaill L.E., Kehoe S.M., Hatton C., et al. High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade. Blood 2011, 117:2433-2440.
22. Kim K.E., Gu C.Y., Thakur S., Vieira E., Lin J.C., Rabson A.B. Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes. Oncogene 2000, 19:1334-1345.
23. Kloeker S., Wadzinski B.E. Purification and identification of a novel subunit of protein serine/threonine phosphatase 4. J. Biol. Chem. 1999, 274:5339-5347.
24. Lee D.H., Pan Y., Kanner S., Sung P., Borowiec J.A., Chowdhury D. A PP4 phosphatase complex dephosphorylates RPA2 to facilitate DNA repair via homologous recombination. Nat. Struct. Mol. Biol. 2010, 17:365-372.
25. Lenz G., Davis R.E., Ngo V.N., Lam L., George T.C., Wright G.W., Dave S.S., Zhao H., Xu W.H., Rosenwald A., et al. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 2008, 319:1676-1679.
26. Li S., Wang L., Berman M.A., Zhang Y., Dorf M.E. RNAi screen in mouse astrocytes identifies phosphatases that regulate NF-kappaB signaling. Mol. Cell 2006, 24:497-509.
27. Li H.Y., Liu H., Wang C.H., Zhang J.Y., Man J.H., Gao Y.F., Zhang P.J., Li W.H., Zhao J., Pan X., et al. Deactivation of the kinase IKK by CUEDC2 through recruitment of the phosphatase PP1. Nat. Immunol. 2008, 9:533-541.
28. Mercurio F., Zhu H.Y., Murray B.W., Shevchenko A., Bennett B.L., Li J.W., Young D.B., Barbosa M., Mann M., Manning A., Rao A. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 1997, 278:860-866.
29. Peter M.E., Kischkel F.C., Scheuerpflug C.G., Medema J.P., Debatin K.M., Krammer P.H. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex. Eur. J. Immunol. 1997, 27:1207-1212.
30. Ruland J., Mak T.W. From antigen to activation: specific signal transduction pathways linking antigen receptors to NF-kappaB. Semin. Immunol. 2003, 15:177-183.
31. Ruland J., Mak T.W. Transducing signals from antigen receptors to nuclear factor kappaB. Immunol. Rev. 2003, 193:93-100.
32. Shui J.W., Hu M.C.T., Tan T.H. Conditional knockout mice reveal an essential role of protein phosphatase 4 in thymocyte development and pre-T-cell receptor signaling. Mol. Cell. Biol. 2007, 27:79-91.
33. Skinnider B.F., Mak T.W. The role of cytokines in classical Hodgkin lymphoma. Blood 2002, 99:4283-4297.
34. Sors A., Jean-Louis F., Pellet C., Laroche L., Dubertret L., Courtois G., Bachelez H., Michel L. Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis. Blood 2006, 107:2354-2363.
35. Staudt L.M. Oncogenic Activation of NF-κB. Cold Spring Harb. Perspect. Biol. 2010, 2:a000109.
36. Swerdlow S.H., Campo E., Harris N.L., Jaffee E.S., Pileri S.A., Stein H., Thiele J., Vardiman J.W. Tumours of Hematopoietic and Lymphoid Tissues 2008, IARC Press, Lyon, France. Fourth Edition.
37. Swift S., Lorens J., Achacosus P., Nolan G.P. Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. Curr Protoc Immunol. 2001, p. Unit 10.17C.
38. Vallabhapurapu S., Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 2009, 27:693-733.
39. Weil R., Israël A. Deciphering the pathway from the TCR to NF-kappaB. Cell Death Differ. 2006, 13:826-833.
40. Yeh P.Y., Yeh K.H., Chuang S.E., Song Y.C., Cheng A.L. Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-kappaB activation by protein phosphatase 4-mediated NF-kappaB p65 Thr dephosphorylation. J. Biol. Chem. 2004, 279:26143-26148.
41. Zhang X.H., Ozawa Y., Lee H., Wen Y.D., Tan T.H., Wadzinski B.E., Seto E. Histone deacetylase 3 (HDAC3) activity is regulated by interaction with protein serine/threonine phosphatase 4. Genes Dev. 2005, 19:827-839.